Biopeer Blog Debuts at Bio-IT World Conference + Expo



A new life sciences blog – Biopeer – will officially make its debut on the third and final day of the 2005 Bio-IT World Conference + Expo. The blog – a co-venture between Boston-based Global Seed Capital and Dot Lab Ltd. of Christchurch, NZ – can be found at www.biopeer.com..

Co-founder and editor of Biopeer is Eric Gerritsen, a former vice president for Lycos and founder and principal of Global Seed Capital. Internet relates to the life sciences market, Gerritsen says he has studied how the Internet relates to the life sciences market, especially “the ways in which the Web was going to affect all parts of the healthcare food chain, from discovery to health care delivery.”

Motivation to launch Biopeer came from the dismal productivity figures plaguing the drug industry. For all of the $100 billion spent globally on drug discovery every year, very few drugs – just 15 in 2003 – emerge the other end. “At the heart of that productivity problem lies the classic problem of information being trapped in silos,” says Gerritsen. He adds that “too much of the discovery research paradigm is based in three places in the world – USA, UK, and Switzerland – leaving out a huge amount of thinking talent in India, China, Brazil, Eastern Europe, and Russia.”

“Biopeer aims to get some of that information out of the silos and some of that great talent into the game,” says Gerritsen. The site has been running for about two months in beta mode, and is already attracting around 5,000 unique readers. The site is targeted at private and public sector research personnel, student and postdoc researchers, medical advocacy groups, as well as members of the general public that have a vested interest in seeing research in specific areas move ahead.

The site already covers more than 30 research topics, and is aiming for 100. Key areas include stem cells, bioinformatics, women’s health, and topical subjects of global interest like avian flu.

“Blogging has clearly become part of the mainstream Internet media world,” says Gerritsen. “When you combine blogging with RSS (Really Simple Syndication) and the ability to push content directly to users’ computers, you have a very powerful publishing architecture that is of great benefit to life sciences researchers.”

According to the Pew Internet & American Life Project, 11 million Americans have created blogs and some 32 million American adults read blogs.

Particular effort has been made to make Biopeer a truly international effort, recognizing that although research is done globally those efforts often do not make it to into the rarified circles of the current research paradigm.

“The team involved in Biopeer have in the past created some of the largest and most geographically diverse online communities on the Internet. We are now bringing this proven ability to create global Web-based communities to the challenge of finding better ways forward in health care innovation,” said Gerritsen. “We aim to bring a whole lot more people into the challenge of finding medical therapies that can benefit mankind,” he added.

Click here to login and leave a comment.  

0 Comments

Add Comment

Text Only 2000 character limit

Page 1 of 1



White Papers & Special Reports

sgi whp 2
Managing the Modern Genomics Data Flood
Sponsored by SGI

Managing and storing the perfect storm of multi-disciplined data pouring from next generation sequencers and other omics instruments is a central challenge in life sciences. Discover in this paper how the SGI ArcFiniti storage solution, optimized for unstructured genomics and life sciences data can: 

  • Reduce costs, proactively protect data integrity, and deliver the high performance I/O required for genomics data processing and analysis.  
  • Effectively manage capacities from 156TB to 1.4PB as a disk based, integrated hardware and software platform 


sgi - whp 1
Turning Genomics Data into Practical Insight
Sponsored by SGI

With worldwide sequencing capacity approaching 13 quadrillion DNA bases annually turning genomics data into knowledge is a true computational challenge. Read this paper and learn how the SGI UV coherent shared memory platform can:  

  • Speed results time while cost competitively tackling the most difficult computational problems across all omics disciplines. 
  • Push performance by scaling to extraordinary levels, up to 256 sockets (2,560 cores, 4,096 threads) per single system (one OS image). 

Provide support for up to 16TB of coherent shared memory in a single system image enabling extreme efficiency across a wide range of compute demands. 



accerlys-logo_2012_wh
New Complimentary Market Survey…
Collaborations and Communications Within Drug Discovery Research
Sponsored by Accelrys
This survey was conducted by the Cambridge Healthtech Media Group in January, 2012. It was sponsored by Accelrys related to their HEOS initiative to gather valid information around externalizing collaborative research while improving communications in the cloud. With 310 qualified industry respondents the survey findings reveal useful usage and trends patterns.  An insightful follow-on discussion and webinar related to this survey, and the HEOS by Scynexis SaaS portal is also available on the Bio-IT World website for complementary viewing.
 


Job Openings

tessella logo 
Scientific Software Engineer
Boston MA
$70,000 to $95,000
 

Tessella delivers software engineering and consulting services to leading pharmaceutical and biotech companies. We are recruiting Software Engineersto work with skilled bioinformaticians and scientists to identify business needs and recommend and develop technical solutions. Applicants require BS, MS or PhD in bioinformatics, biology or chemistry and 2+ years of software development in either: Java, C#, C++, C or VB.NET. 

Apply at http://jobs.tessella.com   

 

oxford nanopore logo 


 Early Access Collaborations Managers
Oxford Nanopore Technologies is developing a novel technology, GridIONTM for the direct, electronic analysis of DNA/RNA and other analytes.  As the system approaches the market, we are building a team of technically knowledgeable, highly motivated candidates with excellent customer service and facilitation skills to join our company as Collaboration Managers.  This is a unique opportunity to work with world-leading genomics customers throughout the early adoption phase of a new generation of DNA sequencing technology.. This is a facilitative, enabling role with responsibility for managing technology development collaborations with key customers at leading genomics institutions.  It will include long term management of the collaboration plan and milestones and associated meetings and documentation. Click here to find out more and apply   

Oxford Nanopore's GridION technology, VP, Sales and Marketing Oxford Nanopore Technologies is a fast-moving technology company that is developing a novel electronic molecular analysis technology. The technology is adaptable for the analysis of DNA/RNA, proteins, chemicals and other molecules.  It is therefore suitable for use in a variety of markets including scientific research and clinical applications.  As the technology approaches the market, Oxford Nanopore is seeking a visionary VP of sales and marketing to join the senior team.  The candidate will embrace the opportunities afforded by entering the market with a truly disruptive technology that has the potential to expand the number of users and the variety of applications in each target market.  This is a rare opportunity to influence the commercial strategy at an early phase of its commercial lifetime, in a well funded company.  Oxford Nanopore welcomes applications from candidates with a track record of high-level strategic commercial  leadership, who wish to apply a fresh approach to existing markets.  Experience in Life Sciences/DNA sequencing is central to this role, however we will consider your application if you have experience of disruptive technologies in other related industries.  We are particularly interested in candidates with strong expertise in the use of digital technologies for sales and marketing of scientific/technical products.  Click to  Apply  


 

For reprints and/or copyright permission, please contact  Tim McLucas, (781) 972-1342, tmclucas@healthtech.com .